HBV drug resistance methods
AssigneeInnogenetics N.V.
InventorAbdurrahman Mithat Bozdayi
Life of this patent
Estimating the term…
Loading patent…
AssigneeInnogenetics N.V.
InventorAbdurrahman Mithat Bozdayi
Estimating the term…
New polymorphisms in the nucleic acid sequences of the DNA polymerase/reverse transcriptase open reading frame and viral surface antigen open reading frame of the hepatitis B virus are reported. In particular, the present invention relates to the mutation YMDD→YSDD in the HBV reverse transcriptase domain and to the W196V mutation in the small HBV viral surface antigen. Said polymorphisms are affecting the detection of drug resistance mutations by genotypic methods and diagnostic kits based thereon. The present invention relates to methods and diagnostic kits for detection of a HBV virus comprising said nucleic acid polymorphisms. In particular, those methods utilizing oligonucleotides capable of hybridizing to said HBV nucleic acid polymorphisms are envisaged.
An isolated HBV polynucleic acid comprising a reverse transcriptase encoding domain, said reverse transcriptase encoding domain comprising a serine encoding codon at the position corresponding to position 204 of sequence P7RT (position 108 of SEQ ID NO:4).
An isolated HBV DNA polymerase/reverse transcriptase protein, said protein comprising a reverse transcriptase domain, said reverse transcriptase domain comprising a serine at the position corresponding to position 204 of sequence P7RT (position 108 of SEQ ID NO:4).
A method for detecting the presence of an HBV in a biological sample, said method comprising the step of detecting the presence of an HBV polynucleic acid comprising a reverse transcriptase encoding domain, said reverse transcriptase encoding domain comprising a serine encoding codon at the position corresponding to position 204 of sequence P7RT (position 108 of SEQ ID NO:4), said method comprising:
A method for detecting resistance to lamivudine or a combination of antiviral drugs comprising lamivudine of an HBV virus present in a biological sample, said method comprising the step of detecting the presence of an HBV polynucleic acid comprising a reverse transcriptase encoding domain, said reverse transcriptase encoding domain comprising a serine encoding codon at position 204, said method comprising:
A method for detecting resistance to lamivudine or a combination of antiviral drugs comprising lamivudine of an HBV virus present in a biological sample, said method comprising the step of detecting the presence of an HBV polynucleic acid comprising a reverse transcriptase encoding domain, said reverse transcriptase encoding domain comprising a serine encoding codon at the position corresponding to position 204 of sequence P7RT (position 108 of SEQ ID NO:4), said method comprising:
A diagnostic kit for detecting the presence of an HBV in a biological sample comprising an oligonucleotide capable of discriminating, in said HBV polynucleic acid, a codon at the position corresponding to position 204 of sequence P7RT (position 108 of SEQ ID NO:4) encoding a serine from a codon at the position corresponding to position 204 of sequence P7RT (position 108 of SEQ ID NO:4) encoding a methionine, valine or isoleucine.
Dependencies are inferred from the claim text.